Answers are grounded in this paper and cite their sources.
Background Increasing antimicrobial resistance complicates community-acquired urinary tract infection (UTI) management. Moreover, the impact of emerging treatments like sodium-glucose cotransporter-2 (SGLT2) inhibitors on urinary ecology remains underexplored. This study analyzes microbiological profiles, resistance patterns, and the influence of SGLT2 inhibitors in a Primary Care setting in Southern Spain. Methods We conducted a retrospective observational study of community-acquired UTI in adult patients during 2022. Variables analyzed included isolated microorganisms, antimicrobial susceptibility, and clinical factors such as diabetes, functional dependence, and prior antibiotic or SGLT2 inhibitor use. Patients under 18 years of age and polymicrobial contamination (three or more isolates) were excluded to ensure a homogeneous sample to ensure a homogeneous sample of community-acquired monobacterial infections. Results A total of 489 positive urine cultures were analyzed (89.3% women; 71.2% > 51 years). Escherichia coli remained the predominant pathogen (64.4%), followed by Klebsiella pneumoniae (17.7%). Resistance rates for E. coli were high for ampicillin (62.3%) and ciprofloxacin (28.4%) but remained low for phosphomycin (1.9%) and nitrofurantoin (1.9%). Notably, in unadjusted analyses, patients treated with SGLT2 inhibitors showed a higher prevalence of K. pneumoniae (7.7% vs 2.5%; p = 0.024); however, this association did not remain statistically significant after multivariable adjustment (adjusted odds ratio (OR) 2.20; 95% confidence interval (CI) [0.72–6.43]; p = 0.200). Diabetes mellitus (DM) remained independently associated with K. pneumoniae isolation in the adjusted model (adjusted OR 1.88; 95% CI [1.01–3.41]; p = 0.045). Conclusions While E. coli remains the leading uropathogen, with susceptibility patterns supporting phosphomycin and nitrofurantoin as first-line empirical therapies, DM, rather than SGLT2 inhibitor use, was independently associated with K. pneumoniae isolation. The unadjusted signal observed with SGLT2 inhibitors should be considered an exploratory, hypothesis-generating finding requiring confirmation in larger prospective cohorts.
No takes yet. Share an insight, caveat, or question.
Ruiz-Ruiz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: